Reports
Sale
Latin America Veterinary Vaccines Market Share, Size, Trends, Forecast: By Vaccine Type: Livestock Vaccines, Companion Animal Vaccines, Others; By Route of Administration: Oral, Parenteral, Others; By Distribution Channels; Regional Analysis; Market Dynamics; Competitive Landscape; Key Trends and Developments in the Market; 2024-2032
Latin America Veterinary Vaccines Market Outlook
The market size for veterinary vaccines in Latin America reached a value of more than USD 400.77 million in 2023. The Latin America veterinary vaccines market is expected to grow at a CAGR of 6.50% between 2024 and 2032, reaching a value of USD 704.79 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends in the Market
Veterinary vaccines are prescribed and given to animals to improve their health and to prevent the occurrence and transmission of diseases. The different types of vaccines available for veterinary patients are recombinant, modified live virus, and killed virus. Vaccination to animals can also be given through their food or injected to them directly.
Technological advancements such as invention of DNA technology and DNA vaccines have improved the health of animals. New immunisation technologies have been developed that has proved to be very efficient in veterinary vaccines, further fuelling the growth of the market.
Animal owners are becoming aware of new veterinary vaccines as they are the most concerned about their animal’s health. Marking a key trend in the market, more and more people are adopting pets and investing in their vaccinations, supporting the growth of the Latin America veterinary vaccines market.
Key players have been doing research and development to fuel the market growth which has led to the development of recombinant vaccines that have advantages such as non-exposure to the pathogen. Such developments help in the growth of the market.
Market Analysis
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on vaccine type, the Latin America veterinary vaccines market can be divided into livestock vaccines, companion animal vaccines, and other types of vaccines. Livestock vaccines are further subdivided into porcine vaccines, bovine vaccines, and poultry vaccines, among others. Companion animal vaccines are subcategorised into canine vaccines, feline vaccines, and equine vaccines, among others.
On the basis of route of administration, the market is divided into oral, parenteral, and others. By distributional channel, the market is segmented into veterinary hospitals and clinics, pharmacies and drug stores, and online, among others. Based on country, the market is divided into Brazil, Mexico, Argentina, Peru, Columbia, Uruguay, Chile, Ecuador, Costa Rica, and the Dominican Republic, among others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the Latin America veterinary vaccines market covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
- Boehringer Ingelheim International GmbH
- Elanco Animal Health Inc.
- Zoetis Services LLC
- Biogenesis Bago SA
- Benten Biotech SRL
- Ourofino Animal Health
- VETANCO S.A.
- SANPHAR
- Compañía Cibeles SA
- König S.A
- Laboratorios Andoci S.A.
- Others
Market Share by Vaccine Type
Livestock vaccines are provided to animals such as cattle, pigs, and poultry, to protect them against illnesses and diseases. Sickness can quickly spread amongst livestock as they are kept together in large numbers, increasing the importance of vaccination and the livestock segment in the Latin America veterinary vaccines market. Lack of vaccination can also lead to increased death rates among livestock, hampering the sales and profits of owners, thereby increasing the demand for vaccinations.
Companion animals such as dogs, cats, and horses are in close proximity to their owners, who often grow strong attachments to the companion animals. This strong attachment drives more pet owners to invest in vaccines for their pets, protecting them from various diseases especially those that are not curable. Vaccination is considered more economical and effective than treatment in many cases.
Market Share by Route of Administration
Parenteral immunisation technique is the most often used means of providing vaccination to animals, including livestock and companion animals. There are three major types of parenteral immunisation, including intramuscular, subcutaneous, and intradermal. The accuracy and effectiveness of parenteral routes of administration has led to hold a leading share in the Latin America veterinary vaccines market.
Oral immunisation is popular for companion animals where pet owners would like to prevent the stress of an injection on their pet. However, oral administration requires pet owners to be highly vigilant to ensure that the vaccine has been consumed properly. New techniques such as mucosal vaccination are expected to witness growth in the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
Boehringer Ingelheim International GmbH founded in 1885 has its headquarter in Germany. It is a research-driven pharmaceutical company that deals with the health of both humans and animals. They discover, develop, manufacture, and then market their innovative products dedicated for healthcare.
Elanco Animal Health Inc. is a pharmaceutical company that was established in 1954 and has its headquarters in Indiana, United States. It is an American company which manufactures and supplies medicines and vaccines for pets and farm animals.
Zoetis Services LLC established in 1952 is based out of New Jersey, United States. It is an animal health company that provide their customers with quality vaccines, diagnostic products, and medicines along with a range of other services.
Other market players include Biogenesis Bago SA, Benten Biotech SRL, Ourofino Animal Health, VETANCO S.A., SANPHAR, Compañía Cibeles SA, König S.A, and Laboratorios Andoci S.A., among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Vaccine Type |
|
| Breakup by Route of Administration |
|
| Breakup by Distribution Channels |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Market Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Industry Opportunities and Challenges
8 Latin America Veterinary Vaccines Market Analysis
8.1 Key Industry Highlights
8.2 Latin America Veterinary Vaccines Historical Market (2018-2023)
8.3 Latin America Veterinary Vaccines Market Forecast (2024-2032)
8.4 Latin America Veterinary Vaccines Market by Vaccine Type
8.4.1 Livestock Vaccines
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.1.3 Breakup by Type
8.4.1.3.1 Porcine Vaccines
8.4.1.3.2 Bovine Vaccines
8.4.1.3.3 Poultry Vaccines
8.4.1.3.4 Others
8.4.2 Companion Animal Vaccines
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.2.3 Breakup by Type
8.4.2.3.1 Canine Vaccines
8.4.2.3.2 Feline Vaccines
8.4.2.3.3 Equine Vaccines
8.4.2.3.4 Others
8.4.3 Others
8.5 Latin America Veterinary Vaccines Market by Route of Administration
8.5.1 Oral
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Parenteral
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Others
8.6 Latin America Veterinary Vaccines Market by Distribution Channels
8.6.1 Veterinary Hospitals and Clinics
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Pharmacies and Drug Stores
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Online
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Others
8.7 Latin America Veterinary Vaccines Market by Country
8.7.1 Brazil
8.7.2 Mexico
8.7.3 Argentina
8.7.4 Peru
8.7.5 Colombia
8.7.6 Uruguay
8.7.7 Chile
8.7.8 Ecuador
8.7.9 Costa Rica
8.7.10 The Dominican Republic
8.7.11 Others
9 Regional Analysis
9.1 Brazil
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Mexico
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
9.3 Argentina
9.3.1 Historical Trend (2018-2023)
9.3.2 Forecast Trend (2024-2032)
9.4 Peru
9.4.1 Historical Trend (2018-2023)
9.4.2 Forecast Trend (2024-2032)
9.5 Uruguay
9.5.1 Historical Trend (2018-2023)
9.5.2 Forecast Trend (2024-2032)
9.6 Ecuador
9.6.1 Historical Trend (2018-2023)
9.6.2 Forecast Trend (2024-2032)
9.7 Costa Rica
9.7.1 Historical Trend (2018-2023)
9.7.2 Forecast Trend (2024-2032)
9.8 The Dominican Republic
9.8.1 Historical Trend (2018-2023)
9.8.2 Forecast Trend (2024-2032)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
11 Price Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Boehringer Ingelheim International GmbH
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Elanco Animal Health Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Zoetis Services LLC
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Biogenesis Bago SA
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Benten Biotech SRL
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Ourofino Animal Health
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 VETANCO S.A.
12.2.7.1 Company Overview
12.2.7.2 Product Portfolio
12.2.7.3 Demographic Reach and Achievements
12.2.7.4 Certifications
12.2.8 SANPHAR
12.2.8.1 Company Overview
12.2.8.2 Product Portfolio
12.2.8.3 Demographic Reach and Achievements
12.2.8.4 Certifications
12.2.9 Compañía Cibeles SA
12.2.9.1 Company Overview
12.2.9.2 Product Portfolio
12.2.9.3 Demographic Reach and Achievements
12.2.9.4 Certifications
12.2.10 König S.A
12.2.10.1 Company Overview
12.2.10.2 Product Portfolio
12.2.10.3 Demographic Reach and Achievements
12.2.10.4 Certifications
12.2.11 Laboratorios Andoci, S.A.
12.2.11.1 Company Overview
12.2.11.2 Product Portfolio
12.2.11.3 Demographic Reach and Achievements
12.2.11.4 Certifications
12.2.12 Others
13 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Latin America Veterinary Vaccine Market: Key Industry Highlights, 2018 and 2032
2. Latin America Veterinary Vaccine Historical Market: Breakup by Vaccine Type (USD Million), 2018-2023
3. Latin America Veterinary Vaccine Market Forecast: Breakup by Vaccine Type (USD Million), 2024-2032
4. Latin America Veterinary Vaccine Historical Market: Breakup by Route of Administration (USD Million), 2018-2023
5. Latin America Veterinary Vaccine Market Forecast: Breakup by Route of Administration (USD Million), 2024-2032
6. Latin America Veterinary Vaccine Historical Market: Breakup by Distribution Channels (USD Million), 2018-2023
7. Latin America Veterinary Vaccine Market Forecast: Breakup by Distribution Channels (USD Million), 2024-2032
8. Latin America Veterinary Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
9. Latin America Veterinary Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Latin America Veterinary Vaccine Market Structure
Key Questions Answered in the Report
The market size for veterinary vaccines in Latin America reached a value of more than USD 400.77 million in 2023.
The market is expected to grow at a CAGR of 6.50% between 2024 and 2032.
The major market drivers are increased adoption of pets, high spending on pet care, and increase in adoption of veterinary immunisation for livestock.
The market size for veterinary vaccines in Latin America is expected to reach a value of more than USD 704.79 million in 2032.
The key trends of the market are technological advancements, increasing awareness regarding importance of veterinary vaccines, and development of recombinant vaccines.
Key market players include Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., Zoetis Services LLC, Biogenesis Bago SA, Benten Biotech SRL, Ourofino Animal Health, VETANCO S.A., SANPHAR, Compañía Cibeles SA, König S.A, and Laboratorios Andoci S.A., among others.
Veterinary vaccines are prescribed and given to animals to prevent the occurrence and transmission of diseases.
The different types of vaccines available for veterinary patients are recombinant, modified live virus, and killed virus.
Latin America veterinary vaccines market is segmented based on vaccine type, route of administration, distribution channel, and country.
Vaccination to animals can also be administered through an injection or given through their food.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 2199
$1799
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3199
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4199
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5199
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER